GLP-1防治糖尿病视网膜病变的研究进展被引量：6

Research advance in GLP-1 for the treatment of diabetic retinopathy

下载PDF

导出

摘要胰高血糖素样肽-1(glucagon-like peptide-1,GLP-1)是一种肠促胰岛素,目前临床中主要用于控制2型糖尿病患者的血糖。近来有研究发现GLP-1及其受体在人体视网膜中表达。现关于GLP-1及其类似物对糖尿病视网膜病变的防治成为研究热点。本文就GLP-1及其类似物对糖尿病视网膜病变治疗的新进展作一综述。 Glucagon like peptide1(GLP1)is an incretin hormone that is currently used clinically to control blood glucose in patients with type2diabetes mellitus.Recent studies have found that GLP1and its receptors are expressed in the human retina.Now GLP1and its analogues for the prevention and treatment of diabetic retinopathy has become a research focus,so this article will give a brief review on the recent advances in GLP1and its analogues for the treatment of DR.

作者雷雨郑宏华陈小红梅雪陈梅珠 LEI Yu;ZHENG Hong Hua;CHEN Xiao Hong;MEI Xue;CHEN Mei Zhu

机构地区福州总医院

出处《眼科新进展》 CAS 北大核心 2017年第12期1193-1196,共4页 Recent Advances in Ophthalmology

基金福建省科技重点项目资助(编号:2016Y0067)~~

关键词胰高血糖素样肽-1 糖尿病视网膜病变治疗 glucagon like peptide-1 diabetic retinopathy treatment

分类号 R774 [医药卫生—眼科]

引文网络
相关文献

参考文献7

1张茸,徐亮,刘玉军,马科.胰高血糖素类肽-1缓释珠对大鼠视网膜神经节细胞的保护作用[J].眼科,2009,18(6):414-418. 被引量：5
2周媛,崔浩,刘洪涛,张丽琼.糖尿病对血-视网膜屏障超微结构影响的研究进展[J].国际眼科杂志,2014,14(7):1220-1222. 被引量：11
3杨宇,田敏,吕红彬.糖尿病视网膜病变的治疗进展[J].眼科新进展,2015,35(5):497-500. 被引量：83
4陈小红,王云鹏,陈梅珠.VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J].眼科新进展,2015,35(7):692-696. 被引量：26
5Hui-yan ZHANG,Jian-yong WANG,Gui-shuang YING,Li-ping SHEN,Zhe ZHANG.Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2013,14(5):392-399. 被引量：16
6王少清,毛楠,周萍,汪力,高芳,卫怡勋,樊均明,付平.利拉鲁肽对2型糖尿病大鼠降血压、利水盐的作用机制探讨[J].天津医药,2016,44(7):849-853. 被引量：3
7赵吉飞,杜建英,刘彦章,侯力华.组织激肽释放酶在糖尿病视网膜病变患者血清中的变化及其调节血管新生机制[J].眼科新进展,2016,36(9):844-848. 被引量：4

二级参考文献86

1Ahmadreza Moradi,Yasir Jamal Sepah,Mohammad Ali Sadiq,Humzah Nasir,Salima Kherani,Raafay Sophie,Diana V Do,Quan Dong Nguyen.Vascular endothelial growth factor trap-eye(Aflibercept) for the management of diabetic macular edema[J].World Journal of Diabetes,2013,4(6):303-309. 被引量：8
2Manuel Diaz-Llopis,Patricia Udaondo,Jose Maria Millán,J Fernando Arevalo.Enzymatic vitrectomy for diabetic retinopathy and diabetic macular edema[J].World Journal of Diabetes,2013,4(6):319-323. 被引量：8
3CAI Xiao-ling WANG Fang JI Li-nong.Risk factors of diabetic retinopathy in type 2 diabetic patients[J].Chinese Medical Journal,2006(10):822-826. 被引量：18
4Seki M, Lipton SA. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res, 2008, 173: 495-510.
5Ito Y, Nakamura S, Tanaka H, et al. Memantine protects against secondary neuronal degeneration in lateral geniculate nucleus and superior colliculus after retinal damage in mice. CNS Neurosci Ther, 2008, 14: 192-202.
6Pease ME, Zack DJ, Berlinicke C, et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci, 2009, 50: 2194-2200.
7Gentilella R, Bianchi C, Rossi A, et al. Exenatide: a review from pharmacology to clinical practice. Diabetes Obes Metab, 2009, 11: 544-556.
8Cabou C, Campistron G, Marsollier N, et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sen- sitivity. Diabetes, 2008, 57: 2577-2587.
9Li Y, Perry T, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A, 2009, 106: 1285-1290.
10Tsai RK, Chang CH, Wang HZ. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Exp Eye Res, 2008, 87: 242-250.